hrp0089rfc7.2 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2018
McGlacken-Byrne Sinead
, Jenkinson Allan
, O'Neill Roisin
, Murphy John
Introduction: Empirical research studies suggest that continuous glucose monitoring systems (CGMS) are safe and could optimize neonatal hypoglycaemia management. However, they need to be tested within resource-limited, time-constrained clinical practice. CGMS was piloted in our Level 3 Neonatal Intensive Care Unit (NICU) in June 2017. Five key barriers to its effective implementation were identified: i) Lack of NICU staff confidence in device usage ii) Infant discomfort during...